Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Feb;75(2):293–300. doi: 10.1111/j.1476-5381.1982.tb08785.x

Studies on the bradycardia induced by bepridil.

M Beaughard, M Ferrier, C Labrid, J C Lamar, J Leboeuf, P Piris
PMCID: PMC2071601  PMID: 6985297

Abstract

Bepridil, a novel active compound for prophylactic treatment of anginal attacks, induced persistent bradycardia and a non-specific anti-tachycardial effect, the mechanisms of which were investigated in vitro and in vivo. In vitro perfusion of bepridil in the life-support medium for isolated sino-atrial tissue from rabbit heart, caused a reduction in action potential (AP) spike frequency (recorded by KCl microelectrodes) starting at doses of 5 X 10(-6) M. This effect was dose-dependent up to concentrations of 5 X 10(-5) M, whereupon blockade of sinus activity set in. Bepridil at a dose of 5 X 10(-6) M, induced a concomitant reduction in AP amplitude (falling from 71 +/- 8 mV to 47 +/- 6 mV), maximum systolic depolarization velocity (phase 0) which fell from 1.85 +/- 0.35 V/s to 0.84 +/- 0.28 V/s, together with maximum diastolic depolarization velocity (phase 4) which fell from 38 +/- 3 mV/s to 24 +/- 5 mV/s. In vivo injection of bepridil at a dose of 5 mg/kg (i.v.) into 6 anaesthetized dogs which had undergone ablation of all the extrinsic cardiac afferent nerve supply, together with a bilateral medullo-adrenalectomy, caused a marked reduction in heart rate which fell from 98.7 +/- 4.2 beats/min to 76 +/- 5.3 beats/min sustained for more than 45 min. It is concluded that bepridil reduces heart rate by acting directly on the sinus node.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
293

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayer R., Kalusche D., Kaufmann R., Mannhold R. Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials. Naunyn Schmiedebergs Arch Pharmacol. 1975;290(1):81–97. doi: 10.1007/BF00499991. [DOI] [PubMed] [Google Scholar]
  2. Boucher M., Duchene-Marullaz D. Comparative effects of amiodarone, perhexiline and bepridil on the cardiac rhythms of the unanesthetized dog in chronic heart block. Arch Int Pharmacodyn Ther. 1978 May;233(1):65–75. [PubMed] [Google Scholar]
  3. Brown H. F., Clark A., Noble S. J. Identification of the pace-maker current in frog atrium. J Physiol. 1976 Jul;258(3):521–545. doi: 10.1113/jphysiol.1976.sp011434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown H. F., Giles W., Noble S. J. Membrane currents underlying activity in frog sinus venosus. J Physiol. 1977 Oct;271(3):783–816. doi: 10.1113/jphysiol.1977.sp012026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Canicave J. C., Deu J., Jacq J., Paillet R. Un nouvel antiangoreux, le bépridil. Appréciation de son efficacité par l'épreuve d'effort au cours d'un assai à double insu contre placebo. Therapie. 1980 Sep-Oct;35(5):607–612. [PubMed] [Google Scholar]
  6. Constantin M., Beaughard M., Piris P., Labrid C. Bépridil, un antagoniste fonctionnel de la stimulation adrénergioque-beta1. Dissociation des effets sur la cardiostimulation et sur la lipolyse. J Pharmacol. 1981 Jul-Sep;12(3):239–254. [PubMed] [Google Scholar]
  7. Cosnier D., Duchenne-Marullaz P., Rispat G., Streichenberger G. Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound. Arch Int Pharmacodyn Ther. 1977 Jan;225(1):133–151. [PubMed] [Google Scholar]
  8. DE CARVALHO A. P., DE MELLO W. C., HOFFMAN B. F. Electrophysiological evidence for specialized fiber types in rabbit atrium. Am J Physiol. 1959 Mar;196(3):483–488. doi: 10.1152/ajplegacy.1959.196.3.483. [DOI] [PubMed] [Google Scholar]
  9. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
  10. Goupil N., Lenfant J. The effects of amiodarone on the sinus node activity of the rabbit heart. Eur J Pharmacol. 1976 Sep;39(1):23–31. doi: 10.1016/0014-2999(76)90109-6. [DOI] [PubMed] [Google Scholar]
  11. Irisawa H. Comparative physiology of the cardiac pacemaker mechanism. Physiol Rev. 1978 Apr;58(2):461–498. doi: 10.1152/physrev.1978.58.2.461. [DOI] [PubMed] [Google Scholar]
  12. Kane K. A., Winslow E. Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil. J Cardiovasc Pharmacol. 1980;2(2):193–203. doi: 10.1097/00005344-198003000-00010. [DOI] [PubMed] [Google Scholar]
  13. Labrid C., Grosset A., Dureng G., Mironneau J., Duchene-Marullaz P. Some membrane interactions with bepridil, a new antianginal agent. J Pharmacol Exp Ther. 1979 Dec;211(3):546–554. [PubMed] [Google Scholar]
  14. Lenfant J., Mironneau J., Gargouïl Y. M., Galand G. Analyse de l'activité électrique spontanée du centre de l'automatisme cardiaque de lapin par les inhibiteurs de perméabilités membranaires. C R Acad Sci Hebd Seances Acad Sci D. 1968 Feb 26;266(9):901–904. [PubMed] [Google Scholar]
  15. Lenfant J., Mironneau J. Transport du sodium par le système de cinétique lente de la membrane myocardique sinusale de lapin. J Physiol (Paris) 1970;62 (Suppl 2)(2):293–293. [PubMed] [Google Scholar]
  16. Michelin M. T., Cheucle-Beaughard M., Duchene-Marullaz P. Comparative effects of amiodarone, bepridil and perhexiline on coronary venous flow and several cardiovascular parameters. Arch Int Pharmacodyn Ther. 1980 Jun;245(2):236–248. [PubMed] [Google Scholar]
  17. Noma A., Irisawa H. Effects of calcium ion on the rising phase of the action potential in rabbit sinoatrial node cells. Jpn J Physiol. 1976;26(1):93–99. doi: 10.2170/jjphysiol.26.93. [DOI] [PubMed] [Google Scholar]
  18. Piris P., Beaughard M., Cosnier D., Labrid C. Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog. Arch Int Pharmacodyn Ther. 1978 Sep;235(1):147–164. [PubMed] [Google Scholar]
  19. Reuter H. Properties of two inward membrane currents in the heart. Annu Rev Physiol. 1979;41:413–424. doi: 10.1146/annurev.ph.41.030179.002213. [DOI] [PubMed] [Google Scholar]
  20. Seyama I. Characteristics of the rectifying properties of the sino-atrial node cell of the rabbit. J Physiol. 1976 Feb;255(2):379–397. doi: 10.1113/jphysiol.1976.sp011285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. TRAUTWEIN W., KASSEBAUM D. G. On the mechanism of spontaneous impulse generation in the pacemaker of the heart. J Gen Physiol. 1961 Nov;45:317–330. doi: 10.1085/jgp.45.2.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vogel S., Crampton R., Sperelakis N. Blockade of myocardial slow channels by bepridil (CERM-1978). J Pharmacol Exp Ther. 1979 Sep;210(3):378–385. [PubMed] [Google Scholar]
  23. Wit A. L., Cranefield P. F. Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular nodal tachycardia. Circ Res. 1974 Sep;35(3):413–425. doi: 10.1161/01.res.35.3.413. [DOI] [PubMed] [Google Scholar]
  24. Yamaguchi I., Obayashi K., Mandel W. J. Electrophysiological effects of verapamil. Cardiovasc Res. 1978 Oct;12(10):597–608. doi: 10.1093/cvr/12.10.597. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES